Background: The novel biomarker human epididymis protein 4 (HE4) shows prognostic value in acute heart failure (HF) patients. We measured HE4 levels in patients with chronic heart failure (CHF) and correlated them to HF severity, kidney function, and HF biomarkers, and determined its predictive value.Methods: Serum HE4 levels in patients (n = 101) with stable CHF with reduced left ventricular ejection fraction (LVEFResults: HE4 levels were higher in CHF compared with control subjects (69.2 pmol/L [interquartile range 55.6-93.8] vs 56.1 pmol/L [46.6-69.0]; PConclusions: HE4 levels are increased in CHF, correlate with HF severity and kidney function, and predict HF outcome.</p
Background: Information on the pathophysiological differences between heart failure with reduced eje...
Abstract Background The prognostic value of human epididymis protein 4 (HE4) in patients with ischem...
Heart failure (HF) is a clinical syndrome characterized by typical signs and symptoms caused by a st...
Background: The novel biomarker human epididymis protein 4 (HE4) shows prognostic value in acute hea...
AbstractBackgroundThe novel biomarker human epididymis protein 4 (HE4) shows prognostic value in acu...
This study investigated clinical determinants and added prognostic value of HE4 as a biomarker not p...
Objectives This study investigated clinical determinants and added prognostic value of HE4 as a biom...
Objectives This study investigated clinical determinants and added prognostic value of HE4 as a biom...
Plasma biomarkers are useful tools in the diagnosis and prognosis of heart failure (HF). In the last...
Despite treatment advances in heart failure with reduced ejection fraction, its prognosis remains po...
International audienceBACKGROUND: Underlying mechanisms in heart failure (HF) with preserved ejectio...
Biomarkers are widely used and studied in heart failure. Most studies have described the utility and...
Biomarker discovery and new insights into the pathophysiology of heart failure with reduced ejection...
Background: Information on the pathophysiological differences between heart failure with reduced eje...
Abstract Background The prognostic value of human epididymis protein 4 (HE4) in patients with ischem...
Heart failure (HF) is a clinical syndrome characterized by typical signs and symptoms caused by a st...
Background: The novel biomarker human epididymis protein 4 (HE4) shows prognostic value in acute hea...
AbstractBackgroundThe novel biomarker human epididymis protein 4 (HE4) shows prognostic value in acu...
This study investigated clinical determinants and added prognostic value of HE4 as a biomarker not p...
Objectives This study investigated clinical determinants and added prognostic value of HE4 as a biom...
Objectives This study investigated clinical determinants and added prognostic value of HE4 as a biom...
Plasma biomarkers are useful tools in the diagnosis and prognosis of heart failure (HF). In the last...
Despite treatment advances in heart failure with reduced ejection fraction, its prognosis remains po...
International audienceBACKGROUND: Underlying mechanisms in heart failure (HF) with preserved ejectio...
Biomarkers are widely used and studied in heart failure. Most studies have described the utility and...
Biomarker discovery and new insights into the pathophysiology of heart failure with reduced ejection...
Background: Information on the pathophysiological differences between heart failure with reduced eje...
Abstract Background The prognostic value of human epididymis protein 4 (HE4) in patients with ischem...
Heart failure (HF) is a clinical syndrome characterized by typical signs and symptoms caused by a st...